The World Desk · slice 04

Health & Bio Desk

Approvals, trials, and the research frontier — where a single regulatory decision reprices a molecule, a company, or a standard of care. This desk reads the health slice of the lattice, from FDA actions to the oncology literature.

$1.6T — the global pharmaceutical market — industry estimates.

As of 2026-07-03 · live snapshot.

Contracts & awards

From the federal public record (SAM.gov · USAspending) — the money actually moving, not the press release about it.

On the desk wire

Names native to this desk moving across the whole lattice right now — click through for momentum, coverage, and the read.

In 10 domains · 57 mentions today

FDA

In 10 verticals across 9 domains

In 3 domains · 70 mentions today

Colorectal Cancer

In 3 verticals across 2 domains

In 5 domains · 16 mentions today

Immunotherapy

In 5 verticals across 4 domains

In 3 domains · 21 mentions today

KRAS

In 3 verticals across 2 domains

In 3 domains · 7 mentions today

ctDNA

In 3 verticals across 2 domains

In the coverage

The desk’s read of what its sources reported most recently.

Questions the desk is watching

FDA: what happens next, and what would change the read?Colorectal Cancer: what happens next, and what would change the read?FDA: which decisions are actually moving right now — and what happens next?Cancer research: what changed in the record this week, and why does it matter?
THE HEALTH & BIO DESK BRIEF

What this desk sees, in your inbox — the record, the moves, and the read, written for managers whose portfolio is the world.

Informational only — event intelligence, not investment advice. Market-size figures are editorial estimates with sources as noted; contract and award lines are drawn from public federal records via our tracked pipelines.